Financial results for the first semester of 2007
Innate Pharma SA anounced its financial results for the first semester of 2007: operational execution according to plan; growth in revenue limits burn rate despite increase in R&D spending.
Financials and Corporate
Number of shares and voting rights, as of July 31, 2007
Innate Pharma SA has released the total number of shares outstanding and voting rights, as of July 31, 2007.
Changes in the composition of Innate Pharma's Supervisory Board
Innate Pharma S.A. announced changes in the composition of its Supervisory Board.
Innate Pharma will hold its AGM of Shareholders on June 26, 2007, in Marseilles, France
Innate Pharma S.A. will hold its Annual General Meeting of Shareholders on June 26, 2007, in Marseilles, France. An information meeting open to shareholders, analysts, investors and journalists will...
Number of shares and voting rights, as of April 30, 2007
Innate Pharma SA has released the total number of shares outstanding and voting rights, as of April 30, 2007.
Turnover of 1.5 million euros for the first quarter of 2007
Innate Pharma S.A. announced a turnover of 1.5 million euros for the first quarter of 2007.
Financial results for 2006
Innate Pharma SA announces its financial results for 2006: Sharp increase in R&D activities (+75%), notably in clinics.
Number of shares and voting rights, as of January 31, 2007
Innate Pharma SA has released the total number of shares outstanding and voting rights, as of January 31, 2007.
Operating revenue of 8.4 million euros in 2006
Innate Pharma SA announced today operating revenue of 8.4 million euros in 2006. Turnover amounted to 6.2 million euros, including 1.7 million euros in the fourth quarter closed on December 31, 2006.
Operating revenue of 8.4 million euros in 2006
Innate Pharma SA announced today operating revenue of 8.4 million euros in 2006. Turnover amounted to 6.2 million euros, including 1.7 million euros in the fourth quarter closed on December 31, 2006.